| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6118477 | International Journal of Antimicrobial Agents | 2011 | 8 Pages |
Abstract
Multidrug-resistant Acinetobacter baumannii (MDR-AB) infections are difficult to treat owing to the extremely limited armamentarium. The present review reports all available treatment options against MDR-AB, including single molecules, combination schemes, and alternative modes of antimicrobial administration. Additionally, a group of recently reported peptides with anti-MDR-AB activity is described.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Ioannis K. Neonakis, Demetrios A. Spandidos, Efthimia Petinaki,